| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANXA2
|
annexin A2
|
|
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
|
|
BCR
|
breakpoint cluster region
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CA9
|
carbonic anhydrase IX
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CD163
|
CD163 molecule
|
|
CD209
|
CD209 molecule
|
|
CD34
|
CD34 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
CPA6
|
carboxypeptidase A6
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
EDN3
|
endothelin 3
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
F2
|
coagulation factor II (thrombin)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
GDF15
|
growth differentiation factor 15
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GPC3
|
glypican 3
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
IBSP
|
integrin-binding sialoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFI30
|
interferon, gamma-inducible protein 30
|
|
IL17A
|
interleukin 17A
|
|
IL6
|
interleukin 6
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB5
|
integrin, beta 5
|
|
ITGB6
|
integrin, beta 6
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
JAG1
|
jagged 1
|
|
LAMB3
|
laminin, beta 3
|
|
LCN2
|
lipocalin 2
|
|
LOX
|
lysyl oxidase
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MGP
|
matrix Gla protein
|
|
MIA
|
melanoma inhibitory activity
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSLN
|
mesothelin
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PROM1
|
prominin 1
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RHOA
|
ras homolog family member A
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100B
|
S100 calcium binding protein B
|
|
SMAD7
|
SMAD family member 7
|
|
SMTN
|
smoothelin
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPP1
|
secreted phosphoprotein 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STMN1
|
stathmin 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TFCP2
|
transcription factor CP2
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
USF1
|
upstream transcription factor 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VTN
|
vitronectin
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
